Arkansas Children's Hospital/University of Arkansas for Medical Sciences

Little Rock, Arkansas 72202

0 studies enrolling now · 5 studies all time

What they study most

Bronchopulmonary Dysplasia, Diabetes Mellitus, Type 1, Diabetic Nephropathy, Eosinophilic Esophagitis, Respiratory Syncytial Virus Infections

Studies at this site

• Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD) — Completed
• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis — Completed
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years — Completed
• Matrix Metalloproteinases and Diabetic Nephropathy — Completed
• Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age — Completed